Litigation Details for CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2023)
✉ Email this page to a colleague
CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2023)
| Docket | ⤷ Try a Trial | Date Filed | 2023-03-17 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-05-15 |
| Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Patents | 10,006,924; 10,151,763; 10,166,242; 10,166,243; 10,195,214; 10,231,983; 10,314,850; 10,500,216; 8,921,348; 9,829,495; 9,943,526 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-05-02 | 26 | Answer to Complaint AND Counterclaim | 526, ’242, ’243, and ’214 patents, in addition to U.S. Patent Nos. 10,006,924, 10,151,763, 10,231,983,… U.S. Patent No. 8,921,348 (“the ’348 patent”) and U.S. Patent No. 9,829,495 (“the ’495 patent”). See….S. Patent No. 10,166,243 (“the ’243 patent”), and U.S. Patent No. 10,195,214 (“the ’214 patent”). Corcept…infringement of U.S. Patent Nos. 10,842,800 (“the ’800 patent”) and 10,842,801 (“the ’801 patent”). …infringed U.S. Patent Nos. 10,842,800 (“the ’800 patent”) and 10,842,801 (“the ’801 patent”) (collectively | External link to document |
| 2023-05-10 | 29 | Letter | infringed U.S. Patent No. 10,166,242 (“the ’242 patent”), U.S. Patent No. 10,166,243 (“the ’243 patent”), and… U.S. Patent No. 8,921,348 (“the ’348 patent”) and U.S. Patent No. 9,829,495 (“the ’495 patent”) by filing…U.S. Patent No. 10,842,800 (“the ’800 patent”) and U.S. Patent No. 10,842,801 (“the ’801 patent”); …allegations of infringement of U.S. Patent No. 9,943,526 (“the ’526 patent”); WHEREAS, on February…and U.S. Patent No. 10,195,214 (“the ’214 patent”); WHEREAS, on February 21, 2019, C.A. Nos | External link to document |
| 2023-05-15 | 30 | Order of Dismissal AND Stipulation and Order | infringed U.S. Patent No. 10,166,242 (“the ’242 patent”), U.S. Patent No. 10,166,243 (“the ’243 patent”), and… U.S. Patent No. 8,921,348 (“the ’348 patent”) and U.S. Patent No. 9,829,495 (“the ’495 patent”) by filing…U.S. Patent No. 10,842,800 (“the ’800 patent”) and U.S. Patent No. 10,842,801 (“the ’801 patent”); …allegations of infringement of U.S. Patent No. 9,943,526 (“the ’526 patent”); WHEREAS, on February…and U.S. Patent No. 10,195,214 (“the ’214 patent”); WHEREAS, on February 21, 2019, C.A. Nos | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
